We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Innovative eLearning Interface Seamlessly Connects Competency Data

By LabMedica International staff writers
Posted on 03 Aug 2016
Print article
Image: The eLearning interface combines three information systems needed to manage operators (Photo courtesy of Telcor).
Image: The eLearning interface combines three information systems needed to manage operators (Photo courtesy of Telcor).
A novel eLearning interface automatically provides a consolidated view of each operator’s point of care testing (POCT) tests performed and competencies completed, along with updated employee information.

The TELCOR (Lincoln, NE, USA) eLearning interface combines three information systems needed to manage operators: a learning management system (LMS), a human resource information system (HRIS, which provided employment status updates to the LMS), and TELCOR QML, which houses the patient and quality control sample information needed to recertify operators and send operator lists to critical POCT devices. By combing the systems, LMS/HRIS errors and omissions associated with manual entry are eliminated.

In addition, College of American Pathologists (CAP), Medicare and Medicaid (CMS), and Joint Commission inspections become more productive and efficient because operator and competency record updates, along with the count of tests performed by each operator, have been combined into one system. Automatically completing competency requirements also allows seamless continuity of patient care when sending operator updates to POCT devices for those who successfully completed their competency requirements, and oversight of those who have not. The TELCOR eLearning Interface will be presented at AACC 2016.

The QML eLearning interface also facilitates operator management by automatically adding new operators; automatically inactivating existing operators; and automatically updating operator demographics such as name and location changes. The system also automatically certifies operators based on samples performed, and can also expand competency components beyond quizzes, such as direct observation completion and status of patient testing, recording and reporting of patient test results, direct observation of instrument maintenance and calibration, and observing problem solving skills.

The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.

Related Links:
TELCOR
American Association for Clinical Chemistry
Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chagas Disease Test
LIAISON Chagas
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.